E

Epinomics

ATAC-seq based epigenomic analytics platform

Infographic Specialist

Full-Time
No salary listed
Mid
San Francisco, CA, USA
In PersonThe role is in the Bay Area.
Art, Graphics & AnimationGraphic Design

About the job

Responsibilities
  • Conceptualize and design web interfaces and data visualization concepts that successfully translate business goals and requirements.
  • Work with Interaction Designers, copywriters, Product Managers, and Marketing team members to understand project needs and successfully implement the brand.
  • Work with IT to assure deployment and appropriate implementation of products that are true to the original design intent.
  • Proactively contribute to an open and productive atmosphere within the design team.
  • Prepare estimates, plan schedules, and create comps.
  • Champion design rationale when presenting to internal clients and project team members.
  • Adhere to the company visual design standards and branding guidelines to maintain consistency and quality across applications and products.
  • Attend design reviews and usability testing to iterate designs.

About the company

Epinomics provided an epigenomics platform that uses ATAC-seq to map chromatin accessibility and gene regulation from a small number of cells, supporting drug development and biomarker discovery. It combines this high-sensitivity epigenomic assay with a data analytics engine to interpret regulatory patterns and predict responses in areas like immuno-oncology. The company stood out by delivering cell-efficient, high-resolution epigenetic insights through collaborations with pharma, biotech, and academia. Its goal was to speed therapeutic development and biomarker discovery by turning dynamic epigenetic data into actionable insights, and its team/technology were later integrated into 10x Genomics’ Chromium Single Cell ATAC Solution.

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

San Francisco, California

Founded

2013

Get referred to Epinomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 10x updated Epi ATAC documentation on September 17, 2026, showing active commercialization.
  • 10x won a Delaware jury verdict against Parse on August 28, 2026.
  • Chromatin accessibility remains embedded in 10x’s Chromium platform, sustaining recurring reagent demand.

What critics are saying

  • Epinomics no longer operates independently; 10x Genomics absorbed it in August 2018.
  • 10x faces fierce competition from Parse Biosciences and Qiagen in single-cell sequencing.
  • If 10x deprioritizes ATAC, Epinomics’ technology becomes a niche legacy product.

What makes Epinomics unique

  • Epinomics’ ATAC-seq IP became 10x Genomics’ Chromium Single Cell ATAC platform in 2018.
  • Howard Chang and William Greenleaf invented ATAC-seq, giving Epinomics deep scientific credibility.
  • Its small-sample chromatin accessibility workflow differentiated it from older bulk epigenomics assays.

Help us improve and share your feedback! Did you find this helpful?